6th Annual IPO Report

OnMarket

IPOs returned an average of 15.2% for 2021, outperforming the ASX200 by 2.1%.

OnMarket 2021 IPO Report

OnMarket is pleased to release the 6th Annual IPO Report - detailing 2021 IPO activity and providing insight into the Australian IPO Market for 2022.

For regular readers it won’t surprise you that our message is the same as other years. 2021 IPOs have yet again outperformed the market with an average end of year return of 15.2%, outperforming the ASX 200 by 2.1%. 

2021 was a record year for the number of IPOs on ASX, with a total of 204 IPOs on the ASX raising a combined $13.4b. An increase from $5.6b across 79 listings in 2020.

Throughout the first half of the year, there were 67 new listings. Investors in H1 were rewarded, with H1 IPOs outperforming the ASX 200 by 9.3% come 31 December. In H2, IPO volume surged, with 67% of 2021 IPOs occurring in the second half of the year, raising almost 74% of the total capital raised in 2021. 

To download the 2021 IPO Report, or IPO reports from the last 5 years, please follow the links below.

 

Regards,

The OnMarket Team

 

Discover investment opportunities here.

 

NASDAQ IPO Offer Closed

GenEmbryomics Ltd NASDAQ: XGEN

Providing next generation genetic testing for the global IVF industry

 

Nasdaq IPO only open to Professional, Sophisticated and Experienced investors

 

GenEmbryomics Ltd (NASDAQ: XGEN) is an Australian genomics-based company providing the ability to screen IVF embryos for over 3,200 severe and fatal genetic diseases. Their flagship test provides genetic testing via whole genome sequencing reducing the risk of having a child with a genetic disorder. Targeting the US$36bn global assisted fertility market, the test is being commercialised in the US with Progenesis Inc., a global fertility services provider.

$1.00Price
Up to US$5.2 millionSize of Offer
21 Mar 25Offer Open
28 Mar 25Pay By
CSF Register for early access

CHEFIN Australia Pty Ltd

Reshaping the ever-growing private dining market

 

CHEFIN brings diners and top private chefs together to create unforgettable dining experiences, backed by a scalable and proven business model. Since its inception, CHEFIN has generated $6M in revenue, built a network of 1,035 C-level chefs, and successfully hosted 3,000 bookings for over 118,580 diners.

CSF Closed Mar 2025

Prohibition Liquor Co. Ltd

The Prohibition Liquor Co. Ltd CSF offer has closed successfully. Prohibition has grown into one of Australia’s most awarded and respected distilleries, earning hundreds of international accolades. They are now embarking on an exciting new chapter—expanding to the historic Seppeltsfield Distillery in the Barossa Valley

Fully Funded

$2.6 million

Raised

1,128

Investors